Search Within

Li-Xuan Qin

  1. "MSK Grad Students"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Biostatistics Service (12)
  2. Epidemiology and Biostatistics (12)
  3. GSK Faculty (12)
  4. MSK Grad Students (12)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Sarcoma Surgeons (11)

More Groups

People
  1. Samuel Singer (11)
  2. Aimee Crago (9)
  3. Cristina Antonescu (9)
  4. William Tap (8)
  5. Edmund Bartlett (7)
  6. Mark Dickson (7)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Annals of Oncology (2)
  2. Clinical Cancer Research (2)
  3. Annals of Surgery (1)
  4. Annals of Surgical Oncology (1)
  5. JAMA Oncology (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Nature Publishing Group (2)
  4. Oxford University Press (2)
  5. American Medical Association (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Histologic subvariant predicts outcome in primary retroperitoneal well- differentiated liposarcoma
    Meeting Abstract

    Li, G. Z.; Lee, J.; Whiting, K. A.; Qin, L. X.; Bartlett, E. K.; Crago, A. M.; Brennan, M.; Hameed, M. R.; Singer, S.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma
    Journal Article

    Bartlett, E. K.; Curtin, C. E.; Seier, K.; Qin, L. X.; Hameed, M.; Yoon, S. S.; Crago, A. M.; Brennan, M. F.; Singer, S.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion
    Journal Article

    Cai, X. C.; Zhang, T.; Kim, E. J.; Jiang, M.; Wang, K.; Wang, J.; Chen, S.; Zhang, N.; Wu, H.; Li, F.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
    Journal Article

    Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Barlas, A.; Manova, K.; Schwartz, G. K.; Crago, A. M.; Singer, S.; more...
    Oncogene (2018)

    Fulltext@MSK | Save